168 related articles for article (PubMed ID: 11816743)
1. [Human histocompatibility HLA system. Considerations in the light of current concepts. II. Immunogenetic function].
Kedzierska A; Turowski G
Przegl Lek; 2001; 58(6):509-12. PubMed ID: 11816743
[TBL] [Abstract][Full Text] [Related]
2. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
3. [HLA polymorphism in the susceptibility or resistance to dilated cardiomyopathy].
Martinetti M; Salvaneschi L; Graziano G; Arbustini E; Diegoli M; Dondi E; Pizzochero C; Gavazzi A
G Ital Cardiol; 1992 Jan; 22(1):73-83. PubMed ID: 1624072
[TBL] [Abstract][Full Text] [Related]
4. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of the HLA complex.
Fischer GF; Mayr WR
Wien Klin Wochenschr; 2001 Oct; 113(20-21):814-24. PubMed ID: 11732117
[TBL] [Abstract][Full Text] [Related]
6. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
7. The HLA system in blood transfusion.
Navarrete CV
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):511-32. PubMed ID: 11102274
[TBL] [Abstract][Full Text] [Related]
8. [Histocompatibility HLA system of man. Consideration in the light of current concepts. I. Organization and polymorphism].
Kedzierska A; Turowski G
Przegl Lek; 2001; 58(5):459-62. PubMed ID: 11603184
[TBL] [Abstract][Full Text] [Related]
9. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
10. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
[TBL] [Abstract][Full Text] [Related]
11. Emerging principles for T cell receptor recognition of antigen in cellular immunity.
Garcia KC; Degano M; Speir JA; Wilson IA
Rev Immunogenet; 1999; 1(1):75-90. PubMed ID: 11256574
[TBL] [Abstract][Full Text] [Related]
12. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
13. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
14. Immune recognition of viral antigens.
Wilson IA; Stanfield RL; Jewell DA; Ghiara JB; Fremont DH; Stura EA
Infect Agents Dis; 1994; 3(2-3):155-62. PubMed ID: 7812653
[TBL] [Abstract][Full Text] [Related]
15. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism and evolution of HLA class I and II genes and molecules.
Little AM; Parham P
Rev Immunogenet; 1999; 1(1):105-23. PubMed ID: 11256568
[TBL] [Abstract][Full Text] [Related]
17. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
Holling TM; Schooten E; van Den Elsen PJ
Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
[TBL] [Abstract][Full Text] [Related]
18. Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?
Uhlin M; Masucci M; Levitsky V
Scand J Immunol; 2006 Dec; 64(6):581-7. PubMed ID: 17083613
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of peptide-MHC class II interaction.
Fleckenstein B; Jung G; Wiesmüller KH
Semin Immunol; 1999 Dec; 11(6):405-16. PubMed ID: 10625594
[TBL] [Abstract][Full Text] [Related]
20. [The HLA system in rheumatic practice: from structure to typing].
Charron D
Rev Rhum Mal Osteoartic; 1989 Apr; 56(5 Pt 2):22-9. PubMed ID: 2662370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
